Olfson, M, Marcus, SC.
National patterns in antidepressant medication treatment. Arch Gen Psychiatry
2009; 66: 848–56.
Exeter, D, Robinson, E, Wheeler, A.
Antidepressant dispensing trends in New Zealand between 2004 and 2007. Aust N Z J Psychiatry
2009; 43: 1131–40.
Deambrosis, P, Chinellato, A, Terrazzani, G, Pullia, G, Giusti, P, Skaper, SD, et al.
Antidepressant drug prescribing patterns to outpatients of an Italian local health authority during the years 1998 to 2008. J Clin Psychopharmacol
2010; 30: 212–5.
Verdoux, H, Tournier, M, Begaud, B.
Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand
2010; 121: 4–10.
Castle, L, Aubert, RE, Verbrugge, RR, Khalid, M, Epstein, RS.
Trends in medication treatment for ADHD. J Atten Disord
2007; 10: 335–42.
Knellwolf, AL, Deligne, J, Chiarotti, F, Auleley, GR, Palmieri, S, Boisgard, CB, et al.
Prevalence and patterns of methylphenidate use in French children and adolescents. Eur J Clin Pharmacol
2008; 64: 311–7.
Prescription drugs debate continues on Capitol Hill. Washington Times
2011; 21 July.
Prescription drugs and the changing patterns of treatment for mental disorders, 1996–2001. Health Aff (Millwood)
2005; 24: 195–205.
IMS Institute for Healthcare Informatics. The Use of Medicines in the United States: Review of 2010. IMS Institute for Healthcare Informatics, 2011 (http://www.imshealth.com/).
De Hert, M, Detraux, J, van Winkel, R, Yu, W, Correll, CU.
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol
2011; Oct 18. Epub ahead of print.
Moret, C, Isaac, M, Briley, M.
Problems associated with long-term treatment with selective serotonin reuptake inhibitors. J Psychopharmacol
2009; 23: 967–74.
NHS Information Centre for Health and Social Care. Data Quality (Prescription Cost Analysis). NHS Information Centre, 2011.
Joint Formulary Committee. British National Formulary (62 edn). BMJ Group and Pharmaceutical Press, 2011.
Ventriglio, A, Vincenti, A, Centorrino, F, Talamo, A, Fitzmaurice, G, Baldessarini, RJ.
Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients. Int Clin Psychopharmacol
2011; 26: 88–95.
Johannessen, LC, Larsson, PG, Rytter, E, Johannessen, SI.
Antiepileptic drugs in epilepsy and other disorders–a population-based study of prescriptions. Epilepsy Res
2009; 87: 31–9.
Committee on the Safety of Medicines. Thiroidazine: Restricted Indicationand New Warnings on Cardio-toxicity. Committee on the Safety of Medicines, 2000.
Pillay, P, Moncrieff, J.
Contribution of psychiatric disorders to occupation of NHS beds: analysis of Hospital Episode Statistics. Psychiatrist
2011; 35: 56–9.
Arias, LH, Lobato, CT, Ortega, S, Velasco, A, Carvajal, A, del Pozo, JG.
Trends in the consumption of antidepressants in Castilla y Leon (Spain). Association between suicide rates and antidepressant drug consumption. Pharmacoepidemiol Drug Saf
2010; 19: 895–900.
Zahl, PH, De Leo, D, Ekeberg, O, Hjelmeland, H, Dieserud, G.
The relationship between sales of SSRI, TCA and suicide rates in the Nordic countries. BMC Psychiatry
2010; 10: 62.
Alexander, GC, Gallagher, SA, Mascola, A, Moloney, RM, Stafford, RS.
Increasing off-label use of antipsychotic medications in the United States, 1995–2008. Pharmacoepidemiol Drug Saf
2011; 20: 177–84.
Moore, M, Yuen, HM, Dunn, N, Mullee, MA, Maskell, J, Kendrick, T.
Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ
2009; 339: b3999.
Osborn, DP, Levy, G, Nazareth, I, Petersen, I, Islam, A, King, MB.
Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry
2007; 64: 242–9.
Ornstein, S, Stuart, G, Jenkins, R.
Depression diagnoses and antidepressant use in primary care practices: a study from the Practice Partner Research Network (PPRNet). J Fam Pract
2000; 49: 68–72.
Lai, LL, Tan, MH, Lai, YC.
Prevalence and factors associated with off-label antidepressant prescriptions for insomnia. Drug Healthc Patient Saf
2011; 3: 27–36.
Freburger, JK, Holmes, GM, Agans, RP, Jackman, AM, Darter, JD, Wallace, AS, et al.
The rising prevalence of chronic low back pain. Arch Intern Med
2009; 169: 251–8.
Kaye, JA, Bradbury, BD, Jick, H.
Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study. Br J Clin Pharmacol
2003; 56: 569–75.
Moreno, C, Laje, G, Blanco, C, Jiang, H, Schmidt, AB, Olfson, M.
National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry
2007; 64: 1032–9.
National Prescribing Centre. Benzodiazepines and newer hypnotics. MeReC Bulletin
2005; 15: 17–20.